Oculis Holding AG OCS
NASDAQ OCS
$9.03 -0.10 (-1.10%)
As of: Sep 30, 2026 · 9:34 AM EDT

Oculis Holding AG (OCS) Debt Ratio (2021 - 2022)

Updated

Oculis Holding AG's (OCS) Debt Ratio stood at 3.30 in Q4 2022, up 69.0% from 1.96 a year earlier.

Analysis

Oculis Holding AG (OCS) Debt Ratio (2021 - 2022) Analysis & Trends

  • Across earlier years, Debt Ratio came in at 1.96 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 0.24
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 0.52
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 0.42
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 0.31
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 0.00
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 0.60
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 0.53
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Oculis Holding AG 473.32 Mn 473.32 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 3.30
Dec 31, 2021 1.96
API Access

Oculis Holding AG Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=OCS&period=max&api_key=YOUR_API_KEY